Lest we forget:
Statements from Joe Moscato, in the Feb. 26 conference call:
"We will execute, keep executing. My goal and my only goal
is to provide a platform for all of you long shareholders in Generex to get the
fruits of what we're doing. It's very important to me."
"That is huge. You're looking at a $40 billion industry in wounds alone. If we
can capture 2%, and 3%, the cost of money for me is quite reasonable. What
we're doing, quite reasonable."
"We're doing a lot of stuff. We have done a lot of stuff in the last six months.
The stuff we've done is unheard of. I don't see many companies executing on
the level that Generex is. We'll continue to do that.
I'm just excited about the next wave of stuff. Because each wave takes a long
time to get together. A lot of lawyers, a lot of finance guys, and a lot of
figuring out, but we have been doing that. We will continue on doing that. "
"We haven't really reflected or realized any of the value on the new
acquisitions yet, as well as all the new endeavors that were involved in. But,
as quarters go by, that will come all together."
"I really appreciate that. As I stated, this management team is investor centric.
We care about you folks. For sure, we're going to do right by our
shareholders. That's all we've cared about since we've taken over the
Company. We'll continue to do so. We'll continue to build value. Hopefully, all of our shareholders will benefit. That's the most important thing to me and this
team."
Okay. As I have stated, even when we first took over the company, we
announced, our acquisitional strategy as part of the overall plan. The biggest
plot of what we do and our model. We have no interest in acquiring
companies where we have to create the wheel.
What we're acquiring first are great management teams or great operators, or
great management teams with great science that can get through the clinic.
Or, great management teams that are commercializing , "Now we'll start
sales."
"Then, revenues will be evident. Again, for us to go in and replace
management teams, and put in new staff, it's not really what we want to do.
It's not really our model. Though, we've been doing it on a few areas as of
recent. "
Insert-tag-here"Other than that, all of the acquisitions have great management teams. All of
the proposed potential acquisitions have great management teams and great
staff."
Statements from Joe Moscato, in the Feb. 26 conference call:
"We will execute, keep executing. My goal and my only goal
is to provide a platform for all of you long shareholders in Generex to get the
fruits of what we're doing. It's very important to me."
"That is huge. You're looking at a $40 billion industry in wounds alone. If we
can capture 2%, and 3%, the cost of money for me is quite reasonable. What
we're doing, quite reasonable."
"We're doing a lot of stuff. We have done a lot of stuff in the last six months.
The stuff we've done is unheard of. I don't see many companies executing on
the level that Generex is. We'll continue to do that.
I'm just excited about the next wave of stuff. Because each wave takes a long
time to get together. A lot of lawyers, a lot of finance guys, and a lot of
figuring out, but we have been doing that. We will continue on doing that. "
"We haven't really reflected or realized any of the value on the new
acquisitions yet, as well as all the new endeavors that were involved in. But,
as quarters go by, that will come all together."
"I really appreciate that. As I stated, this management team is investor centric.
We care about you folks. For sure, we're going to do right by our
shareholders. That's all we've cared about since we've taken over the
Company. We'll continue to do so. We'll continue to build value. Hopefully, all of our shareholders will benefit. That's the most important thing to me and this
team."
Okay. As I have stated, even when we first took over the company, we
announced, our acquisitional strategy as part of the overall plan. The biggest
plot of what we do and our model. We have no interest in acquiring
companies where we have to create the wheel.
What we're acquiring first are great management teams or great operators, or
great management teams with great science that can get through the clinic.
Or, great management teams that are commercializing , "Now we'll start
sales."
"Then, revenues will be evident. Again, for us to go in and replace
management teams, and put in new staff, it's not really what we want to do.
It's not really our model. Though, we've been doing it on a few areas as of
recent. "
Insert-tag-here"Other than that, all of the acquisitions have great management teams. All of
the proposed potential acquisitions have great management teams and great
staff."
